JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB184699

Anti-ERK1 + ERK2 抗体 [EPR17526]

Anti-ERK1 + ERK2 antibody [EPR17526]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • 了解详情

5

(1 Review)

|

(415 Publications)

Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) is a rabbit monoclonal antibody detecting ERK1 + ERK2 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 250 publications

查看别名

ERK1, PRKM3, MAPK3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase isoform p44, Microtubule-associated protein 2 kinase, p44-ERK1, ERK-1, p44-MAPK

13 Images
Immunocytochemistry - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • ICC

Lab

Immunocytochemistry - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

ab288063 staining ERK1 (phospho T202 + Y204) + ERK2 (phospho T185 + Y187) in untreated, PMA treated and PMA + LP treated HeLa cells. The cells were fixed with 100% Methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab288063 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour magenta). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

The image shows increased nuclear staining after 24hr serum starvation followed by treatment with PMA (200nM, 15min) of HeLa cells. The Lambda Phoshatase treatment then removes all staining of antibody with no phospho ERK1/2 remaining.

ab184699 was used as a Pan ERK1 + ERK2 control for ab288063. The results showed nuclear staining on untreated, with no increase after PMA treatment and no reduction after PMA + LP treated in HeLa cells.

Immunocytochemistry/ Immunofluorescence - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • ICC/IF

AbReview59872****

Immunocytochemistry/ Immunofluorescence - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

ab184699 staining ERK1 + ERK2 in HeLa cells by ICC/IF (Immunocytochemistry/Immunofluorescence). Cells were fixed with paraformaldehyde and permeabilized with 0.5% Triton X-100. Samples were incubated with primary antibody (1/500 in PBS) for 1 hour at 22°C. A Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed (ab150081) was used as the secondary antibody.

This image is courtesy of an Abreview submitted by Kirk Mcmanus.

Flow Cytometry (Intracellular) - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

Intracellular flow cytometric analysis of A431 (Human epidermoid carcinoma) cells labeling ERK1 + ERK2 with ab184699 at 1/440 dilution (red) compared with a rabbit monoclonal IgG isotype control (black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/150 dilution was used as the secondary antibody.

Immunocytochemistry/ Immunofluorescence - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling ERK1 + ERK2 with ab184699 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Confocal image showing both nuclear and cytoplasmic staining on HeLa cell line. The nuclear counter stain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows :
-ve control 1 : ab184699 at 1/250 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2 : ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.

Immunocytochemistry - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • ICC

Lab

Immunocytochemistry - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

ab288063 staining ERK1 (phospho T202 + Y204) + ERK2 (phospho T185 + Y187) in untreated, PMA treated and PMA + LP treated NIH/3T3 cells. The cells were fixed with 100% Methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab288063 at 5µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour magenta). Nuclear DNA was labelled with DAPI (shown in blue).

Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.

Also suitable in cells fixed with 4% paraformaldehyde (10 min).

The image shows increased nuclear staining after 24hr serum starvation followed by treatment with PMA (200nM, 15min) of NIH/3T3 cells. The Lambda Phoshatase treatment then removes all staining of antibody with no phospho ERK1/2 remaining.

ab184699 was used as a Pan ERK1 + ERK2 control for ab288063. The results showed nuclear staining on untreated, with no increase after PMA treatment and no reduction after PMA + LP treated in NIH/3T3 cells.

Immunoprecipitation - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • IP

Supplier Data

Immunoprecipitation - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

ERK1 + ERK2 were immunoprecipitated from 1mg of PC-12 (Rat adrenal gland pheochromocytoma) whole cell extract with ab184699 at 1/70 dilution. Western blot was performed from the immunoprecipitate using ab184699 at 1/5000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.

Lane 1 : PC-12 whole cell extract. Lane 2 : PBS instead of PC-12 whole cell extract.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.

44kDa band represents ERK1. 42kDa band represents ERK2.

All lanes:

Immunoprecipitation - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699)

Predicted band size: 41 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Supplier Data

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

44kDa band represents ERK1. 42kDa band represents ERK2.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) at 1/10000 dilution

Lane 1:

Human fetal brain lysates at 10 µg

Lane 2:

Human fetal heart lysates at 10 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution

Predicted band size: 41 kDa

Observed band size: 42 kDa,44 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Lab

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

Lanes 1-2 : Merged signal (red and green). Green - ab184699 observed at 44 kDa. Red - loading control ab8245 observed at 37 kDa.

ab184699 Anti-ERK1 + ERK2 antibody [EPR17526] was shown to specifically react with ERK2 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265052 (knockout cell lysate ab257525) was used. Wild-type and ERK2 knockout samples were subjected to SDS-PAGE. ab184699 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 10000 Dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) at 1/10000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

MAPK1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human MAPK1 (ERK2) knockout HeLa cell line (<a href='/products/cell-lines/human-mapk1-erk2-knockout-hela-cell-line-ab265052'>ab265052</a>)

Predicted band size: 41 kDa

Observed band size: 44 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Supplier Data

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

44kDa band represents ERK1. 42kDa band represents ERK2.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) at 1/50000 dilution

Lane 1:

A431 (Human epidermoid carcinoma) whole cell lysates at 20 µg

Lane 2:

Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysates at 20 µg

Lane 3:

HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysates at 20 µg

Lane 4:

HepG2 (Human liver hepatocellular carcinoma) whole cell lysates at 20 µg

Lane 5:

Human fetal brain lysates at 20 µg

Lane 6:

Human fetal heart lysates at 20 µg

Lane 7:

Human fetal kidney lysates at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 41 kDa

Observed band size: 42 kDa,44 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Lab

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

ab288063 was shown to specifically react with ERK1/2 (pT202+ Y204). The signal was significantly reduced after treat with 10 uM U0126.
Samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5% BSA in TBS-0.1 % Tween® 20 (TBS-T).
ab288063, ab184699 and Anti-Tubulin antibody [DM1A] - Loading Control (ab7291) were incubated overnight at 4°C at 1/1000, 1/10000 and 1/5000 dilutions, respectively.
Blots were developed with Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ERK1 (phospho T202+Y204) + ERK2 (phospho T185+Y187) antibody [EPR25015-F2] (<a href='/products/primary-antibodies/erk1-phospho-t202y204-erk2-phospho-t185y187-antibody-epr25015-f2-ab288063'>ab288063</a>) at 1/1000 dilution

Lane 1:

HeLa cells, serum-starved overnight, treated with U0126 (10 uM, 60 min) at 20 µg

Lane 2:

HeLa cells, serum-starved overnight, treated with TPA (200 nM, 15 min) at 20 µg

Lane 3:

NIH3T3 cells, serum-starved overnight, treated with U0126 (10 uM, 60 min) at 20 µg

Lane 4:

NIH3T3 cells, serum-starved overnight, treated with TPA (200 nM, 15 min) at 20 µg

Lane 5:

A10 cells, serum-starved overnight, treated with U0126 (10 uM, 60 min) at 20 µg

Lane 6:

A10 cells, serum-starved overnight, treated with TPA (200 nM, 15 min) at 20 µg

Secondary

Lanes 1 - 6:

Goat anti-Rabbit IgG H&L 800CW at 1/20000 dilution

Lanes 1 - 6:

Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution

Observed band size: 42 kDa,44 kDa,50 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Supplier Data

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

44kDa band represents ERK1. 42kDa band represents ERK2.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) at 1/10000 dilution

Lane 1:

Mouse brain lysates at 10 µg

Lane 2:

Mouse heart lysates at 10 µg

Lane 3:

Mouse kidney lysates at 10 µg

Lane 4:

Mouse spleen lysates at 10 µg

Lane 5:

Rat brain lysates at 10 µg

Lane 6:

Rat heart lysates at 10 µg

Lane 7:

Rat kidney lysates at 10 µg

Lane 8:

Rat spleen lysates at 10 µg

Lane 9:

C6 (Rat glial tumor cells) whole cell lysates at 10 µg

Lane 10:

RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysates at 10 µg

Lane 11:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysates at 10 µg

Lane 12:

NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysates at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 41 kDa

Observed band size: 42 kDa,44 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Supplier Data

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

Recombinant full length ERK1 protein (ab43623) contains aa1-379.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) at 1/10000 dilution

All lanes:

Recombinant Human ERK1 protein (<a href='/products/unavailable/recombinant-human-erk1-protein-ab43623-ab43623'>ab43623</a>) (<a href='/products/unavailable/recombinant-human-erk1-protein-ab43623-ab43623'>ab43623</a>) at 0.01 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 41 kDa

Observed band size: 44 kDa

false

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)
  • WB

Supplier Data

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (AB184699)

Recombinant full length ERK2 protein (ab43625) contains aa1-360.

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) at 1/10000 dilution

All lanes:

Western blot - Recombinant Human ERK2 protein (<a href='/products/proteins-peptides/recombinant-human-erk2-protein-ab43625'>ab43625</a>) at 0.01 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution

Predicted band size: 41 kDa,52 kDa

Observed band size: 42 kDa

false

不同偶联物与剂型 (8)

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-ERK1 + ERK2 antibody [EPR17526]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-ERK1 + ERK2 antibody [EPR17526]

  • 421 Alexa Fluor® 405

    Alexa Fluor® 405 Anti-ERK1 + ERK2 antibody [EPR17526]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-ERK1 + ERK2 antibody [EPR17526]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-ERK1 + ERK2 antibody [EPR17526]

  • HRP

    HRP Anti-ERK1 + ERK2 antibody [EPR17526]

  • 578 PE

    PE Anti-ERK1 + ERK2 antibody [EPR17526]

  • Carrier free

    Anti-ERK1 + ERK2 antibody [EPR17526] - BSA and Azide free

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR17526

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

WB, IP, ICC/IF, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/440", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/70", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Recombinant full length protein - Human": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "notRecommended", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

产品详情

What is this antibody validated in?
Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of ERK1 + ERK2?
Anti-ERK1 + ERK2 [EPR17526] (ab184699) specifically detects a band for ERK1 + ERK2 (UniProt: P28482) at a molecular weight of 43, 41kDa.

Trusted by the scientific community
Anti-ERK1 + ERK2 [EPR17526] (ab184699) was first used in a scientific publication in 2015 and has been cited over 250 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-ERK1 + ERK2 antibody [EPR17526] (ab184699) has been confirmed by Western blot testing in MAPK1 Knockout HeLa cell line, ab265052.

Other related products
We have a range of other formats of antibody clone [EPR17526] also available for your convenience: ab184699, Carrier free - ab242993

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

ERK1 and ERK2 also known as MAPK3 and MAPK1 respectively are protein kinases involved in the mitogen-activated protein kinase (MAPK) signaling pathway. They share high sequence identity and exhibit similar functions. ERK1 has a molecular weight of approximately 44 kDa while ERK2 weighs around 42 kDa. Both are expressed ubiquitously in various tissues playing roles in diverse cellular processes. These proteins often detected through ERK1/2 western blot analyses present similar ERK protein size and ERK molecular weight characteristics relevant during protein expression studies.
Biological function summary

ERK1 and ERK2 play key roles in cell proliferation differentiation and survival. They form part of a cascade that includes upstream activators such as MEK1/2 and downstream targets including transcription factors. As components of the MAPK signaling complex ERK1/2 regulate gene expression through phosphorylation events impacting cellular responses to various stimuli. Their activation often hinges on growth factors cytokines and stress signals facilitating cellular adaptation to environmental changes.

Pathways

Regarding pathways ERK1/2 sit within the MAPK/ERK pathway and are significant in the Ras/Raf/MEK/ERK cascade one of the foremost signaling mechanisms in cells. They interact with several proteins including Ras and Raf which modulate their activation. This pathway is important for transmitting signals from the cell surface to the DNA in the cell nucleus impacting gene regulation and cell fate decisions. ERK1/2 proteins therefore serve as critical nodes linking extracellular signals to cellular responses ensuring balanced cell function.

ERK1/2 play significant roles in cancer and neurodegenerative diseases. Their overactivation is often linked to oncogenic processes contributing to cell proliferation in cancers. Mutations or dysregulation within the MAPK/ERK pathway including ERK1/2 frequently associate with tumorigenesis. Additionally in neurodegenerative disorders like Alzheimer's disease altered ERK1/2 activity may impact neuronal survival and function often through interaction with amyloid-beta and tau proteins further illustrating their importance in disease pathophysiology.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed : 34497368). MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DEPTOR, FRS2 or GRB10) (PubMed : 35216969). Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade.
See full target information MAPK3

其他靶点

MAPK1

文献 (415)

Recent publications for all applications. Explore the full list and refine your search

CNS neuroscience & therapeutics 31:e70608 PubMed40955046

2025

Gut Microbiota-Bile Acid-Brain Axis and TGR5-ERK1/2 Signaling Mediate ADT-Induced Cognitive Impairment.

Applications

Unspecified application

Species

Unspecified reactive species

Fan Yang,Yanbo Liu,Zhien Zhou,Dong Yang,Weigang Yan

International journal of ophthalmology 18:1426-1432 PubMed40827285

2025

Obtusifolin ameliorates dry eye model in rats by reducing inflammation and blocking MAPK/NF-κB pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Dan Zhu,Xiao-Yang Wu,Liang-Chang Li

Genes & diseases 12:101689 PubMed40821113

2025

RAB26 promotes prostate cancer progression via the MAPK/ERK-TWIST1 signaling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Hexi Wang,Simin Liang,Xiaoyi Du,Guozhi Zhao,Yuanyuan Bai,Junwu Li,Haoyu Xu,Senlin Peng,Ye Yuan,Wei Tang

Scientific reports 15:29488 PubMed40796933

2025

GPER1 is involved in shaping tumor immune microenvironment and its expression is decreased in NSCLC tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenhua Li,Chao Xie,Jingjing Cui,Hui Xu,Dingbiao Li

Investigative ophthalmology & visual science 66:29 PubMed40793857

2025

Inhibiting The uPA/uPAR Pathway Affords Photoreceptor Resilience and Preserves Retinal Function in a Mouse Model of Retinitis Pigmentosa.

Applications

Unspecified application

Species

Unspecified reactive species

Rosario Amato,Alessio Canovai,Alberto Melecchi,Maria De Fenza,Linda Leone,Vincenzo Pavone,Daniele D'Alonzo,Maurizio Cammalleri,Massimo Dal Monte

World journal of gastrointestinal oncology 17:105264 PubMed40697228

2025

Nav1.6 drives colorectal cancer proliferation and invasion through MAPK signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Ming Zhao,Wan-Ying Hong,Jian-Guang Xu,Shui-Quan Lin,Ming-Sheng Liu,Li-Hui Wang,Xu-Li Jiang,Ming Sang,Yang-Bo Lv

The Tohoku journal of experimental medicine : PubMed40670090

2025

Drp1-Dependent Mitochondrial Fission is Involved in Adriamycin Resistance in Gastric Cancer Cells: A Perspective from the BATF2/p53/ERK Regulatory Axis.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Yang,Rong Zeng,Jianlin Song,Ning Ma,Wenchuan Zhu,Tianyan Fu,Tingting Zhang,Fabi Li,Bian Wu

Inflammation : PubMed40586852

2025

Mac-1 Promotes Neutrophil Extracellular Traps Formation via ERK Phosphorylation in Renal Ischemia-Reperfusion Injury.

Applications

Unspecified application

Species

Unspecified reactive species

Luna He,Jialin Wang,Yang Li,Shuan Zhao,Yan Yang,Nana Song,Xiaoyi Zou,Shengzhuo You,Yi Fang,Tsuboi Naotake,Shi Jin,Xiaoqiang Ding,Yiqin Shi

International journal of molecular sciences 26: PubMed40565375

2025

Isostrictiniin Alleviates LPS-Induced Acute Lung Injury via the Regulation of the Keap1-Nrf2/HO-1 and MAPK/NF-κB Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Wanting Ding,Yuan Sun,Wulipan Tuohudaali,Chenyang Li,Yuhan Yao,Jun Zhao

Journal for immunotherapy of cancer 13: PubMed40541272

2025

HVJ-E links Apolipoprotein d to antitumor effects.

Applications

Unspecified application

Species

Unspecified reactive species

Airi Ishibashi,Noriko Ohta,Yuko Uegaki,Hidefumi Suzuki,Katsuya Fukino,Yuuta Hisatomi,Atsushi Tanemura,Riuko Ohashi,Koji Kitamura,Kotaro Saga,Yasuhide Yoshimura,Satoko Inubushi,Kyoso Ishida,Yoko Ino,Yayoi Kimura,Kenjiro Sawada,Tadashi Kimura,Eiji Kiyohara,Kosuke Yusa,Hidehisa Takahashi,Yasufumi Kaneda,Keisuke Nimura
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com